Ensemble of classifiers based data fusion of EEG and MRI for diagnosis of neurodegenerative disorders

The prevalence of Alzheimer\u27s disease (AD), Parkinson\u27s disease (PD), and mild cognitive impairment (MCI) are rising at an alarming rate as the average age of the population increases, especially in developing nations. The efficacy of the new medical treatments critically depends on the ability to diagnose these diseases at the earliest stages. To facilitate the availability of early diagnosis in community hospitals, an accurate, inexpensive, and noninvasive diagnostic tool must be made available. As biomarkers, the event related potentials (ERP) of the electroencephalogram (EEG) - which has previously shown promise in automated diagnosis - in addition to volumetric magnetic resonance imaging (MRI), are relatively low cost and readily available tools that can be used as an automated diagnosis tool. 16-electrode EEG data were collected from 175 subjects afflicted with Alzheimer\u27s disease, Parkinson\u27s disease, mild cognitive impairment, as well as non-disease (normal control) subjects. T2 weighted MRI volumetric data were also collected from 161 of these subjects. Feature extraction methods were used to separate diagnostic information from the raw data. The EEG signals were decomposed using the discrete wavelet transform in order to isolate informative frequency bands. The MR images were processed through segmentation software to provide volumetric data of various brain regions in order to quantize potential brain tissue atrophy. Both of these data sources were utilized in a pattern recognition based classification algorithm to serve as a diagnostic tool for Alzheimer\u27s and Parkinson\u27s disease. Support vector machine and multilayer perceptron classifiers were used to create a classification algorithm trained with the EEG and MRI data. Extracted features were used to train individual classifiers, each learning a particular subset of the training data, whose decisions were combined using decision level fusion. Additionally, a severity analysis was performed to diagnose between various stages of AD as well as a cognitively normal state. The study found that EEG and MRI data hold complimentary information for the diagnosis of AD as well as PD. The use of both data types with a decision level fusion improves diagnostic accuracy over the diagnostic accuracy of each individual data source. In the case of AD only diagnosis, ERP data only provided a 78% diagnostic performance, MRI alone was 89% and ERP and MRI combined was 94%. For PD only diagnosis, ERP only performance was 67%, MRI only was 70%, and combined performance was 78%. MCI only diagnosis exhibited a similar effect with a 71% ERP performance, 82% MRI performance, and 85% combined performance. Diagnosis among three subject groups showed the same trend. For PD, AD, and normal diagnosis ERP only performance was 43%, MRI only was 66%, and combined performance was 71%. The severity analysis for mild AD, severe AD, and normal subjects showed the same combined effect

Enhanced alzheimer’s disease classification scheme using 3d features

Alzheimer’s disease (AD) is a neurodegenerative brain illness that leads to death due to complications. Many studies on AD classification with Magnetic Resonance Imaging (MRI) images were conducted to act as a computer-aided diagnosis. Feature extraction and feature selection were performed to reduce the number of features and extract significant features concurrently. However, the classification of stable mild cognitive impairment (SMCI) and progressive mild cognitive impairment (PMCI) is far from satisfactory due to the high similarity between the groups. Therefore, this research aimed to enhance the AD classification scheme to solve the problem. The proposed method has included shape enhancement before feature extraction to maximize the difference between healthy patients (normal control (NC)+SMCI) and sick patients (PMCI+AD). The sick patient has a thinner brain boundary compared to a healthy patient. Therefore, a 3D opening morphological operation was proposed to eliminate the thinner boundary and restore the thicker boundary. After that, the proposed 3-level 3D Discrete Wavelet Transform (DWT) and Principal Component Analysis (PCA) were combined for feature extraction. Using the Haar filter, 3-level 3D-DWT extracted 3D significant features to improve the classification result. PCA further reduced the number of features by projecting the training set and test set to lower-dimensional space. The number of features was greatly reduced from 2,122,945 to 159. Feature selection was removed from the proposed scheme after realizing the process would eliminate important features to segregate the classification groups. Linear Support Vector Machine (SVM) was employed to perform binary classification. The proposed scheme achieved higher mean accuracy compared to the previous method, which was from 79% to 80%, from 81% to 84%, from 80% to 84 % on the datasets collected at time points of 24 months, 18 months before stable diagnosis and at the stable diagnosis time point, respectively

Machine Learning and Deep Learning Approaches for Brain Disease Diagnosis : Principles and Recent Advances

This work was supported in part by the National Research Foundation of Korea-Grant funded by the Korean Government (Ministry of Science and ICT) under Grant NRF 2020R1A2B5B02002478, and in part by Sejong University through its Faculty Research Program under Grant 20212023.Peer reviewedPublisher PD

Smart-data-driven system for alzheimer disease detection through electroencephalographic signals

Background: Alzheimer’s Disease (AD) stands out as one of the main causes of dementia worldwide and it represents around 65% of all dementia cases, affecting mainly elderly people. AD is composed of three evolutionary stages: Mild Cognitive Impairment (MCI), Mild and Moderate AD (ADM) and Advanced AD (ADA). It is crucial to create a tool for assisting AD diagnosis in its early stages with the aim of halting the disease progression. Methods: The main purpose of this study is to develop a system with the ability of differentiate each disease stage by means of Electroencephalographic Signals (EEG). Thereby, an EEG nonlinear multi-band analysis by Wavelet Packet was performed enabling to extract several features from each study group. Classic Machine Learning (ML) and Deep Learning (DL) methods have been used for data classification per EEG channel. Results: The maximum accuracies obtained were 78.9% (Healthy controls (C) vs. MCI), 81.0% (C vs. ADM), 84.2% (C vs. ADA), 88.9% (MCI vs. ADM), 93.8% (MCI vs. ADA), 77.8% (ADM vs. ADA) and 56.8% (All vs. All). Conclusions: The proposed method outperforms previous studies with the same database by 2% in binary comparison MCI vs. ADM and central and parietal brain regions revealed abnormal activity as AD progresses.info:eu-repo/semantics/publishedVersio

Computer-Aided Diagnoses (CAD) System: An Artificial Neural Network Approach to MRI Analysis and Diagnosis of Alzheimer’s Disease (AD)

Alzheimer’s disease (AD) is a chronic and progressive, irreversible syndrome that deteriorates the cognitive functions. Official death certificates of 2013 reported 84,767 deaths from Alzheimer’s disease, making it the 6th leading cause of death in the United States. The rate of AD is estimated to double by 2050. The neurodegeneration of AD occurs decades before symptoms of dementia are evident. Therefore, having an efficient methodology for the early and proper diagnosis can lead to more effective treatments. Neuroimaging techniques such as magnetic resonance imaging (MRI) can detect changes in the brain of living subjects. Moreover, medical imaging techniques are the best diagnostic tools to determine brain atrophies; however, a significant limitation is the level of training, methodology, and experience of the diagnostician. Thus, Computer aided diagnosis (CAD) systems are part of a promising tool to help improve the diagnostic outcomes. No publications addressing the use of Feedforward Artificial Neural Networks (ANN), and MRI image attributes for the classification of AD were found. Consequently, the focus of this study is to investigate if the use of MRI images, specifically texture and frequency attributes along with a feedforward ANN model, can lead to the classification of individuals with AD. Moreover, this study compared the use of a single view versus a multi-view of MRI images and their performance. The frequency, texture, and MRI views in combination with the feedforward artificial neural network were tested to determine if they were comparable to the clinician’s performance. The clinician’s performances used were 78 percent accuracy, 87 percent sensitivity, 71 percent specificity, and 78 percent precision from a study with 1,073 individuals. The study found that the use of the Discrete Wavelet Transform (DWT) and Fourier Transform (FT) low frequency give comparable results to the clinicians; however, the FT outperformed the clinicians with an accuracy of 85 percent, precision of 87 percent, sensitivity of 90 percent and specificity of 75 percent. In the case of texture, a single texture feature, and the combination of two or more features gave results comparable to the clinicians. However, the Gray level co-occurrence matrix (GLCOM), which is the combination of texture features, was the highest performing texture method with 82 percent accuracy, 86 percent sensitivity, 76 percent specificity, and 86 percent precision. Combination CII (energy and entropy) outperformed all other combinations with 78 percent accuracy, 88 percent sensitivity, 72 percent specificity, and 78 percent precision. Additionally, a combination of views can increase performance for certain texture attributes; however, the axial view outperformed the sagittal and coronal views in the case of frequency attributes. In conclusion, this study found that both texture and frequency characteristics in combinations with a feedforward backpropagation neural network can perform at the level of the clinician and even higher depending on the attribute and the view or combination of views used

Texture Analysis Platform for Imaging Biomarker Research

abstract: The rate of progress in improving survival of patients with solid tumors is slow due to late stage diagnosis and poor tumor characterization processes that fail to effectively reflect the nature of tumor before treatment or the subsequent change in its dynamics because of treatment. Further advancement of targeted therapies relies on advancements in biomarker research. In the context of solid tumors, bio-specimen samples such as biopsies serve as the main source of biomarkers used in the treatment and monitoring of cancer, even though biopsy samples are susceptible to sampling error and more importantly, are local and offer a narrow temporal scope. Because of its established role in cancer care and its non-invasive nature imaging offers the potential to complement the findings of cancer biology. Over the past decade, a compelling body of literature has emerged suggesting a more pivotal role for imaging in the diagnosis, prognosis, and monitoring of diseases. These advances have facilitated the rise of an emerging practice known as Radiomics: the extraction and analysis of large numbers of quantitative features from medical images to improve disease characterization and prediction of outcome. It has been suggested that radiomics can contribute to biomarker discovery by detecting imaging traits that are complementary or interchangeable with other markers. This thesis seeks further advancement of imaging biomarker discovery. This research unfolds over two aims: I) developing a comprehensive methodological pipeline for converting diagnostic imaging data into mineable sources of information, and II) investigating the utility of imaging data in clinical diagnostic applications. Four validation studies were conducted using the radiomics pipeline developed in aim I. These studies had the following goals: (1 distinguishing between benign and malignant head and neck lesions (2) differentiating benign and malignant breast cancers, (3) predicting the status of Human Papillomavirus in head and neck cancers, and (4) predicting neuropsychological performances as they relate to Alzheimer’s disease progression. The long-term objective of this thesis is to improve patient outcome and survival by facilitating incorporation of routine care imaging data into decision making processes.Dissertation/ThesisDoctoral Dissertation Biomedical Informatics 201

Decision-based data fusion of complementary features for the early diagnosis of Alzheimer\u27s disease

As the average life expectancy increases, particularly in developing countries, the prevalence of Alzheimer\u27s disease (AD), which is the most common form of dementia worldwide, has increased dramatically. As there is no cure to stop or reverse the effects of AD, the early diagnosis and detection is of utmost concern. Recent pharmacological advances have shown the ability to slow the progression of AD; however, the efficacy of these treatments is dependent on the ability to detect the disease at the earliest stage possible. Many patients are limited to small community clinics, by geographic and/or financial constraints. Making diagnosis possible at these clinics through an accurate, inexpensive, and noninvasive tool is of great interest. Many tools have been shown to be effective at the early diagnosis of AD. Three in particular are focused upon in this study: event-related potentials (ERPs) in electroencephalogram (EEG) recordings, magnetic resonance imaging (MRI), as well as positron emission tomography (PET). These biomarkers have been shown to contain diagnostically useful information regarding the development of AD in an individual. The combination of these biomarkers, if they provide complementary information, can boost overall diagnostic accuracy of an automated system. EEG data acquired from an auditory oddball paradigm, along with volumetric T2 weighted MRI data and PET imagery representative of metabolic glucose activity in the brain was collected from a cohort of 447 patients, along with other biomarkers and metrics relating to neurodegenerative disease. This study in particular focuses on AD versus control diagnostic ability from the cohort, in addition to AD severity analysis. An assortment of feature extraction methods were employed to extract diagnostically relevant information from raw data. EEG signals were decomposed into frequency bands of interest hrough the discrete wavelet transform (DWT). MRI images were reprocessed to provide volumetric representations of specific regions of interest in the cranium. The PET imagery was segmented into regions of interest representing glucose metabolic rates within the brain. Multi-layer perceptron neural networks were used as the base classifier for the augmented stacked generalization algorithm, creating three overall biomarker experts for AD diagnosis. The features extracted from each biomarker were used to train classifiers on various subsets of the cohort data; the decisions from these classifiers were then combined to achieve decision-based data fusion. This study found that EEG, MRI and PET data each hold complementary information for the diagnosis of AD. The use of all three in tandem provides greater diagnostic accuracy than using any single biomarker alone. The highest accuracy obtained through the EEG expert was 86.1 ±3.2%, with MRI and PET reaching 91.1 +3.2% and 91.2 ±3.9%, respectively. The maximum diagnostic accuracy of these systems averaged 95.0 ±3.1% when all three biomarkers were combined through the decision fusion algorithm described in this study. The severity analysis for AD showed similar results, with combination performance exceeding that of any biomarker expert alone

Data fusion of complementary information from parietal and occipital event related potentials for early diagnosis of Alzheimer\u27s disease

The number of the elderly population affected by Alzheimer\u27s disease is rapidly rising. The need to find an accurate, inexpensive, and non-intrusive procedure that can be made available to community healthcare providers for the early diagnosis of Alzheimer\u27s disease is becoming an increasingly urgent public health concern. Several recent studies have looked at analyzing electroencephalogram signals through the use of many signal processing techniques. While their methods show great promise, the final outcome of these studies has been largely inconclusive. The inherent difficulty of the problem may be the cause of this outcome, but most likely it is due to the inefficient use of the available information, as many of these studies have used only a single EEG source for the analysis. In this contribution, data from the event related potentials of 19 available electrodes of the EEG are analyzed. These signals are decomposed into different frequency bands using multiresolution wavelet analysis. Two data fusion approaches are then investigated: i.) concatenating features before presenting them to a classification algorithm with the expectation of creating a more informative feature space, and ii.) generating multiple classifiers each trained with a different combination of features obtained from various stimuli, electrode, and frequency bands. The classifiers are then combined through the weighted majority vote, product and sum rule combination schemes. The results indicate that a correct diagnosis performance of over 80% can be obtained by combining data primarily from parietal and occipital lobe electrodes. The performance significantly exceeds that reported from community clinic physicians, despite their access to the outcomes of longitudinal monitoring of the patients